Responding to Mpox: Global outbreak, research innovations, and therapeutic strategies

In August 2024, the WHO declared Mpox (formerly known as Monkeypox) a global health emergency due to rising Clade I Mpox cases in Africa and Sweden, highlighting the urgency for coordinated global efforts to monitor and mitigate the spread of the virus.

Harbinger Health raises $140M to study blood-based cancer screening test

Dive Brief: Harbinger Health has raised $140 million to clinically validate a blood-based cancer screening test ahead of a planned launch in 2025. The test

September 28, 2023

Opinion | An Olympic-Sized Miss in Managing COVID-19

Adams was the 20th Surgeon General of the U.S. Noah Lyles’ stunning comeback to win the men’s 100-meter dash and subsequent crowning as the “world’s

August 23, 2024

RP-3 by Replimune for Gastrointestinal Tract Cancer: Likelihood of Approval

RP-3 is under clinical development by Replimune and currently in Phase I for Gastrointestinal Tract Cancer.

November 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.